Cambridge Epigenetix Strengthens Leadership Team to Support Development of Epigenetics-Based Diagnostics

News   Nov 02, 2017

 
Cambridge Epigenetix Strengthens Leadership Team to Support Development of Epigenetics-Based Diagnostics
 
 
 

RELATED ARTICLES

Concept Life Sciences appoints New Group Programme Manager and US Head of Sales

News

Key leadership appointments support integration of the Group and expansion in the US market.

READ MORE

Immunosuppressive Cells in Newborns Play Important Role in Controlling Inflammation in Early Life

News

New research has characterized the transitory presence of myeloid-derived suppressor cells (MDSCs) in mouse and human newborns, revealing a critical role of these cells in regulation of inflammation in the early stages of life.

READ MORE

Blood-vessel-on-a-chip Provides Insight into Novel Anti-Inflammatory Drug Candidate

News

Researchers have discovered that synthetic APC-mimicking small molecules called “parmodulins” provide anti-inflammatory and anti-thrombotic protection to endothelial cells on par with APC’s without interfering with normal blood clotting and coagulation, making them attractive new drug candidates.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE